Search for: "BAYER PHARMACEUTICALS CORP." Results 61 - 80 of 171
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by… [read post]
5 Jul 2013, 5:00 am by Bexis
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 355 (Ill. 1996). [read post]
26 Jun 2009, 7:56 am
Bayer AG and Bayer Corp., et al. where the Question Presented was: Are pharmaceutical “reverse payment” agreementsâ€â [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
Cir. 2014)(quoting Alza Corp. v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction… [read post]
20 Mar 2009, 2:05 am
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 354 (Ill. 1996); Woodill v. [read post]
12 Jun 2009, 10:49 am
Bayer AG and Bayer Corp., et al Issue:  Are pharmaceutical “reverse payment” agreements - whereby the manufacturer of a brand-name drug (and patent holder) pays a generic manufacturer (and alleged patent infringer) to not launch a generic version of the brand-name drug - per se lawful without regard to the amount of cash paid or the strength of the underlying patent challenge? [read post]